RMTG (Regenerative Medical Technology Group) 3-Year Revenue Growth Rate : 218.60% (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group 3-Year Revenue Growth Rate?

Regenerative Medical Technology Group's Revenue per Share for the three months ended in Sep. 2024 was $0.08.

During the past 12 months, Regenerative Medical Technology Group's average Revenue per Share Growth Rate was 34.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 218.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 103.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Regenerative Medical Technology Group was 218.60% per year. The lowest was -9.10% per year. And the median was 111.00% per year.

Competitive Comparison of Regenerative Medical Technology Group's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Regenerative Medical Technology Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerative Medical Technology Group's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's 3-Year Revenue Growth Rate falls into.

Regenerative Medical Technology Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Regenerative Medical Technology Group (OTCPK:RMTG) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Regenerative Medical Technology Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerative Medical Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432

Website

https://www.regenmedtechgroup.com

Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.

Executives

Benito Novas	10 percent owner	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen	director, 10 percent owner, officer: President and CEO	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria	director, 10 percent owner, officer: CEO, Chairman	RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803